Correlation between depression, anxiety, and polymorphonuclear cells’ resilience in ulcerative colitis: the mediating role of heat shock protein 70 by unknown
Vlachos et al. BMC Gastroenterology 2014, 14:77
http://www.biomedcentral.com/1471-230X/14/77RESEARCH ARTICLE Open AccessCorrelation between depression, anxiety, and
polymorphonuclear cells’ resilience in ulcerative
colitis: the mediating role of heat shock protein 70
Ilias I Vlachos1,6*, Calypso Barbatis2, Maria Tsopanomichalou2, Lydia Abou-Assabeh2, Konstantinos Goumas3,
Maria Ginieri-Coccossis4, Marina Economou4, George N Papadimitriou4, Efstratios Patsouris5
and Polyxeni Nicolopoulou-Stamati1Abstract
Background: To investigate whether anxiety and depression levels are associated with Heat Shock Protein 70
(HSP70) induction in the colon of patients with ulcerative colitis (UC).
Methods: The design was cross-sectional. Clinical activity was assessed by the Rachmilewitz Index (CAI). Three
psychometric questionnaires were used: Zung Depression Rating Scale (ZDRS), Spielberg State-Trait Anxiety
Inventory (STAI), Hospital Anxiety and Depression Scale (HADS). Colon biopsies were obtained from each affected
anatomical site. Severity of inflammation was assessed by eosin/hematoxylin. Constitutive (HSP70c) and inducible
(HSP70i) HSP70 expression were immunohistochemically studied.
Results: 29 UC patients were enrolled (69% men). Mean age was 46.5 years (SD: 19.5). Inflammation severity was
moderate in 17 patients, severe in 6, and mild in 6. The mean number of years since diagnosis was 7.9 (SD: 6.5). The
mean CAI was 6.4 (SD: 3.1). In active UC, there was downregulation of HSP70c in inflamed epithelium, without
significant HSP70 induction. In 22/29 cases of active cryptitis, polymorphonuclear cells (PMN) clearly expressed
HSP70i, with weak, focal positivity in the other 7 cases. Except for the hospital anxiety scale, scores in all
psychometric tools were higher in patients with strong HSP70i immunoreactivity in the PMN. Logistic regression
showed a strong positive relationship between HSP70i immunoreactivity in the PMN cells and scores in the trait
anxiety, ZDRS, and hospital depression scales, (Odds ratios 1.3, 1.3, and 1.5; P = 0.018, 0.023, and 0.038; Wald test, 5.6,
5.2, and 4.3 respectively) and a weaker but significant positive correlation with the CAI (Odds ratio 1.654; P = 0.049;
Wald test 3.858).
Conclusion: HSP70 is induced in PMN cells of UC patients and its induction correlates with depression and anxiety levels.
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PsychoneuroimmunologyBackground
Ulcerative colitis (UC) represents one of the major idio-
pathic inflammatory bowel diseases (IBD), along with
Crohn’s disease (CD). Although its etiology remains
unknown, there is evidence of an aberrant response of* Correspondence: vlachos.ilias@gmail.com
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reproduction in any medium, provided the orthe immune system to commensal microbial flora in a
genetically susceptible host [1].
Psychological stress and depression are known to prolong
the clinical course of UC in terms of symptom severity and
relapses [2-4] and it seems that UC patients, compared to
the general population, are significantly more likely to have
a diagnosis of anxiety and major depression [5,6]. Animal
research depicts a causal relationship between experi-
mentally induced depression and increased secretion
of proinflammatory cytokines leading to reactivation of
colitis. Τricyclic antidepressants and selective serotoninel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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fect of proinflammatory cytokines [7,8] as well as to exert
analgesia on IBD patients [9]. Moreover, UC patients seem
to have an increased sympathetic autonomic activity
compared to controls, and the severity of their symp-
toms is associated with measures of personality-related
but not situational anxiety [10]. Mawdsley and colleagues
showed that acute psychological stress induces inflamma-
tory responses in UC patients [3]. UC patients seem to be
influenced more than CD patients by external factors and
to a lesser extent by genetic factors. Identical twin studies
reveal smaller genetic predisposition for the etiology of
UC (10%), compared to the 50% genetic predisposition
of identical twins with CD [11]. In this light, the theory
of neuroimmunomodulation in UC requires further
documentations [12,13].
Heat shock proteins (HSPs) are ubiquitous in all living
organisms and cells and form the most virulent cellular
defense for a variety of stressors that disrupt cell proteins
and threaten cell survival. Types of cellular stress, proven
to promote Hsp induction, are: thermal stress -as stated in
their etymology-, oxidative stress through the forma-
tion of reactive oxygen species (ROS), which disturb the
cell by oxidizing lipids of the membrane, its proteins
and even the cellular DNA leading the cell to apoptosis
or cell death. Other types of cellular stress are bacteria
and bacterial exo-and endotoxins, viral infections, cy-
tokines, ischemia. Psychophysiοlogical stress has also
been associated with HSP70 induction, mainly in ani-
mal models [13,14].
They exist in two forms: the constitutive and the in-
ducible. The inducible form becomes activated under
conditions of cellular stress and exerts cytoprotective
functions [12,13]. Heat shock proteins act as molecular
chaperones by rescuing essential cell proteins and pre-
venting aggregation of denatured ones [15] and they
inhibit cellular apoptosis by suppressing parts of the
apoptotic machinery [16]. Animal studies have shown
that HSPs are also induced in different tissues via the
hypothalamic-pituitary-adrenal (HPA) axis and the sympatho-
adrenomedullary system (SAS) under conditions of psy-
chophysiological stress [17,18].
The inducible HSP70 (Hsp70i), along with the indu-
cible HSP25/27, is associated more with the protection
of the intestinal mucosa compared to other members
of the heat shock protein family. Its downregulation in
IBD, constitutes a potentially dangerous situation,
since the intestinal mucosa becomes susceptible to im-
mune and inflammatory processes [19-21].
Its induction in UC remains a topic of dispute, as rele-
vant publications show evidence of either enhanced
expression or downregulation [19,22]. Psychosomatic re-
search stresses the need for further exploration in humans
of the role that HSPs play as possible mediators betweengut inflammation and susceptibility to psychological
stress [23].
In the present study, we investigated whether anxiety
and depression levels evaluated by relevant psychometric
tools are associated with HSP70 induction in the colon
of patients with UC, as a reflection of the emotional
state on a histological level.Methods
This was a cross-sectional study. Participants were re-
cruited from patients hospitalized for coloscopic investi-
gation for possible relapse of their existing IBD. The
recruitment took place in the gastroenterology depart-
ment of the tertiary care “Hellenic Red Cross Hospital”
in Athens, between October 2008 and June 2010.
The diagnosis of UC was made following the standard
clinical, radiological, and histopathological procedures de-
scribed by the Lockhart-Mummery and Morson criteria
[24]. Patients with CD were excluded, because the differ-
ent nature and progress of the diseases (UC vs. CD) has
proven to lead to Type II statistical errors (false negative
results), when samples of patients are mixed according to
relevant research [23].
Eligible patients were informed about the study aim
and procedures and those who agreed to participate and
signed informed consent were enrolled into the study.
The study was conducted according to the Declaration
of Helsinki and was approved by the General Assembly
of the medical School of the University of Athens with
the protocol number 3049/1.12.03.Study procedures
Disease activity was assessed clinically with the Rachmilewitz
Colitis Activity Index (CAI) [11]. CAI includes the evalu-
ation by a gastroenterologist of seven domains that imply
disease activity: number of stools weekly, blood in stools,
investigator’s global assessment of symptomatic rate, ab-
dominal pain or cramps, temperature due to colitis, extra-
intestinal manifestations, and laboratory findings focused
on sedimentation rate and hemoglobin. A CAI ≥ 6 is con-
sidered indicative of active disease. Disease duration, age,
and gender were also recorded.
The patients completed three psychometric question-
naires: the Zung Depression Rating Scale (ZDRS), the
Spielberg State-Trait Anxiety Inventory (STAI) Form X
I, II as state and as trait, and the Hospital Anxiety and
Depression Scale (HADS).
In addition, intestinal biopsies were taken and were
diagnosed blinded by two pathologists. The type and
severity of inflammation were assessed on each section
with hematoxylin & eosin staining. The site and inten-
sity of expression of HSP70 expression were studied
immunohistochemically.
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We used the Greek standardized versions of three self-
reported instruments frequently used in research con-
cerning anxiety and depression in IBD patients [4]:
The STAI form consists of two 20-items questionnaires
[25,26]. The first questionnaire measures state anxiety, i.e.
how the respondent “feels right now” meaning the time
of completion. The second questionnaire measures trait
anxiety, i.e. how the respondent generally feels. For each
questionnaire, the scores range is 20–80. The cut-point
for clinically significant anxiety is 39–40, scores > 54 are
considered indicative of a mental disorder [27].
The ZDRS [28,29] is a self-rating scale for the measure-
ment of depression. It consists of 20 items that cover
affective, psychological, and somatic symptoms. The re-
spondent specifies the frequency with which the symptom is
experienced (from 1 = little to 4 =most of the time) for the
past several days. The minimum scores is 20 and the max-
imum score is 80. Scores > 50 indicate clinical depression.
The HADS [30,31] was developed to identify possible
and probable cases of anxiety and depression among
patients in non-psychiatry hospital clinics and has been
extensively validated in chronic diseases including IBD
[32]. The HADS consists of two subscales: the HA for
anxiety, and the HD for depression. The minimum
scores is 0 and the maximum score is 21. Scores >7 in-
dicate “possible case”, and > 11 indicate “probable case”.
The questionnaire asks how the respondent has been
feeling during the past week.
Biopsies
Colonic biopsies were obtained from each anatomical
site of the colon, during coloscopy. As control for the
HSP70 monoclonal antibody, biopsies from the normal
xcolon of patients with adenocarcinoma (resection mar-
gins with no presence of active inflammation, no poly-
morphonuclear cells, no histological abnormalities and
more than 20 cm distance from the tumour), were used
after informed consent. No psychometric questionnaires
were given to adenocarcinoma patients.
The tissue was fixed in neutral buffered formalin. Sec-
tions were stained with hematoxylin & eosin. The severity
of active disease was semiquantitatively assessed using an
accepted scoring system ranging from 0–3 as well as the
distinction between actively inflamed from uninvolved
tissues, using a scoring system from 0 to 3 (0 = no activity,
1 =mild, 2 =moderate, 3 = severe) [33,34].
Constitutive and inducible forms of the HSP70 protein
were detected immunohistochemically on 3 μm thick sec-
tions with the Bond-MAX system, Leica Ltd. The follow-
ing mouse monoclonal antibodies were used: anti-HSP70
Ad-2 (clone W27, Lab vision Corp USA, diluted 1:50),
anti-HSP70i (SPA-810, clone C92F3A-5, Stressgen, USA,
diluted 1:25). Both antibodies are specific for mammalianHSP70 and do not crossreact with bacterial antigens.
SPA-810 has been validated in previous methodological
and clinical studies on HSP70 induction [22,35]. HSP70
expression (both constitutive and inducible) was assessed
in each separate biopsy specimen regarding: surface epi-
thelium (nuclear and cytoplasmic), crypts (nuclear and
cytoplasmic), lymphoid tissue, monocytes (MC), and neu-
trophils (PMN), using an accepted system marking: ab-
sence as “0”, low staining as “+/−“, moderate as “+”,
and intense staining as “++” [22,35].
Statistical analysis
Descriptive statistics were used for demographic and
clinical characteristics. Based on the psychometric scale
cut-offs, we distinguished between three levels for anxiety
and depression: normal, significant case, and clinical case.
There was a small number of missing values (4 missing
points in the ZDRS measurements) which were consid-
ered as missing completely at random (MCAR). Pearson
chi-square was used for the comparison of immunore-
activity levels by inflammatory activity. t-tests for inde-
pendent samples, and Mann–Whitney test was used for
comparisons of means in the scales used, between the
group of patients with positive or negative staining in
HSP70i. Logistic regression was used to determine the
effect of psychometric scores on HSP70i immunoreac-
tivity. Although we used the four point scale [22,35] for
the surface epithelium the crypts and the lamina propria,
in PMN cells our attention was driven to those cells that
didn’t show any HSP70 induction, despite active disease.
Therefore, in the statistical analysis we used a dichotom-
ous scale between present or absent HSP70 induction in
PMN cells of active ulcerative colitis patients. PMN cells
were not classified according to the intensity of the stain-
ing but on the basis of positivity or negativity. Moreover,
positive cells were stained (by SPA-810 antigen), while
negative cells were not stained.
Results
29 patients with UC were enrolled, 20 men (69%) and 9
women (31%). The mean age was 46.5 years (SD: 19.5).
Disease activity was mostly moderate (58.6% of patients);
severe disease was present in 20.7% and mild disease in
20.7%. The mean number of years since diagnosis was 7.9
(SD: 6.5) for the 25/29 patients, because 4/29 patients
were not sure about the specific year of diagnosis. 10
patients (35%) were receiving corticosteroids. The mean
CAI was 6.4 (SD: 3.1).
Immunohistochemistry - controls
For the constitutive HSP70, we found strong nuclear
and cytoplasmic expression throughout the epithelium
with the same intensity from the surface to the base of the
crypts and the MC of the lamina propria (Figure 1a, c, e).
Figure 1 Expression of constitutive HSP70 in the epithelium, crypts, and lamina propria of normal and UC tissue. a. Normal tissue.
Surface epithelium. Strong nuclear (arrows) and cytoplasmic positivity (arrow heads). b. UC tissue. Surface epithelium. The surface epithelium
retains nuclear and weak cytoplasmic positivity (arrows). c. Normal tissue. Crypts. Nuclear (arrows) and cytoplasmic positivity (arrow heads). d. UC
tissue. Crypts. Crypts with positive cytoplasm and focal nuclear positivity (arrows) with active cryptitis and positive neutrophils (arrow heads).
e. Normal tissue. Lamina propria. Scattered positive nuclei (arrows). f. UC tissue. Lamina propria. Crypts with negative nuclei (arrow), positive
cytoplasm (arrow head) and positive neutrophils (arrow heads).
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positivity of the surface epithelium, and mild focal nuclear
staining at the base of some crypts. There was nuclear stain-
ing of some MC in the lamina propria (Figure 2a, c, d).
Immunohistochemistry - UC
For the constitutive HSP70, we observed a tendency for
downregulation in both surface epithelium and crypts.Figure 2 Expression of inducible HSP70 in the epithelium, crypts, and
Epithelium. Negative normal surface epithelium (arrows). b. UC tissue. Cryp
(arrow heads). c. Normal tissue. Crypts.Negative nuclei and cytoplasm and
(arrow heads). d. Normal tissue.Lamina propria. Scattered positive nuclei of
heads). e. UC tissue. Purulent material from ulcer. Negative neutrophils in p
(arrows).However, staining was increased in the lamina propria,
mainly MC, and to a lesser degree in the PMN cells
(Figure 1b, d, f ).
For the inducible HSP70, a few of the mild and moder-
ate activity epithelial specimens showed weak staining
on the surface; the severe activity specimens showed
almost no staining. The crypts showed even fewer cases
of weak staining compared to the surface epithelium.lamina propria of normal and UC tissue. a. Normal tissue.
t epithelium. Negative epithelium (arrows) and positive neutrophils
sparse positive nuclei in the lamina propria of normal colonic mucosa
mononuclear cells in the lamina propria of normal mucosa (arrow
urulent material (arrow heads) positive nuclei of mononuclear cells
Table 1 Expression* of constitutive and inducible HSP70 in tissue resection
Controls N = 12 Degree of expression* N = 57
Controls N = 12 UC = Mild N = 24 UC =Moderate N = 27 UC = Severe N = 6
HSP70 constitutive
Surface epithelium
Nucleus ++ (9/12) ++ (13/24) ++ (16/27) ++ (3/6)
+ (1/12) + (2/24) + (5/27) + (1/6)
0– + (1/12) 0 − + (6/24) 0 − + (5/27) 0 − + (2/6)
0 (3/24) 0 (1/27)
Cytoplasm ++ (8/12) ++ (7/24) ++ (5/27) ++ (3/6)
+ (2/12) + (7/24) + (12/27) + (0/6)
0– + (2/12) 0 − + (6/24) 0 − + (8/27) 0 − + (2/6)
0 (4/24) 0 (2/27) 0 (1/6)
Crypts
Nucleus ++ (7/12) ++ (2/24) ++ (13/27) ++ (3/6)
+ (2/12) + (9/24) + (5/27) + (1/6)
0– + (3/12) 0 − + (9/24) 0 − + (8/27) 0 − + (2/6)
0 (4/24) 0 (1/27)
Cytoplasm ++ (7/12) ++ (3/24) ++ (6/27) ++ (3/6)
0– + (4/12) + (8/24) + (11/27) + (0/6)
0 (1/12) 0 − + (9/24) 0 − + (7/27) 0 − + (1/6)
0 (4/24) 0 (3/27) 0 (2/6)
Lamina propria
Mononuclear cells + (6/12) + (14/24) + (18/27) + (5/6)
0 (6/12) 0 (10/24) 0 (9/27) 0 (1/6)
Polymorphonuclear cells 0 (12/12) + (7/24) +(16/27) + (4/6)
0 (17/24) 0 (11/27) 0 (2/6)
HSP70 inducible
Surface epithelium
Nucleus 0– + (2/12) 0 − + (4/24) 0 − +(4/27) ———————
0 (10/12) 0 (20/24) 0 (23/27) 0 (6/6)
Cytoplasm 0– + (4/12) 0 − + (5/24) 0 − +(6/27) 0 − + (2/6)
0 (8/12) 0 (19/24) 0 (21/27) 0 (4/6)
Crypts
Nucleus 0– + (2/12) 0 − + (2/24) 0 − + (2/27) ————————
0 (10/12)) 0 (22/24) 0 (25/27) 0 (6/6)
Cytoplasm 0– + (2/12) ————————— 0 − +(1/27) —————————
0 (10/12) 0 (24/24) 0 (26/27) 0 (6/6)
Lamina propria
Mononuclear cells + (1/12) + (1/24) + (1/27) —————————
0 (11/12) 0 (23/24) 0 (26/27) 0 (6/6)
Polymorphonuclear cells 0 (12/12) + (16/24) + (21/27) + (5/6)
0 (8/24) 0 (6/27) 0 (1/6)
*Staining: no staining, 0; weak, 0– +; medium, +; intense, ++.
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Table 2 Distribution of patients in normal, a significant








State anxiety 17 (58.6) 7 (24.1) 5 (17.2)
Trait anxiety 14 (48.3) 12 (41.4) 3 (10.3)
ZDRS 28 (96.6) - 1 (3.4)
Hospital anxiety 19 (65.5) 5 (17.2) 5 (17.2)
Hospital depression 21 (72.4) 6 (20.7) 2 (6.9)
Abbreviations: ZDRS Zung depression rating scale.
a:Normal: State anxiety 20–39; Trait anxiety 20–39; ZDRS 20–50; Hospital
anxiety 0–7; Hospital depression 0–7.
b:Significant case: State anxiety 40–54; Trait anxiety 40–54; ZDRS not
applicable; Hospital anxiety 8–11; Hospital depression 8–11.
c:Clinical case: State anxiety >54; Trait anxiety >54; ZDRS > 50; Hospital anxiety
>11; Hospital depression ≥11.
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increased in the biopsies from 22 patients regardless of
the severity of the biopsy findings (Table 1) (Figure 2b).
In the biopsies of the rest 7 patients, negative PMN
were observed (2e).
Psychometric tools
Most scores for all psychometric tools were normal
(Table 2). Except for the hospital anxiety scale, scores for
all psychometric tools were higher in patients with posi-
tive immunoreactivity in the PMN cells of the inducible
HSP70 (Table 3). The psychometric scales were selected
in order to increase the reliability and validity of the re-
sults on depression and anxiety. As can be seen in
Table 4, the psychometric scales correlate significantly
to eachother despite the lack of correlation with the
duration of the disease (in years).
The expression of the inducible HSP70 was similar in
patients with and without corticosteroids: 70% positive
immunoreactivity for the inducible HSP70 in those re-
ceiving corticosteroids and 79% in those not receiving
corticosteroids (P = 0.593).
Logistic regression showed a strong positive relation-
ship between immunoreactivity of the inducible HSP70Table 3 Mean scores for psychometric tools, in the total popu
Total mean (SD) N = 29 HSP70i PMN positive
mean (SD) N = 22
HS
me
State anxiety 40.5 (13.2) 43.5 (13.8) 31.
Trait anxiety 39.4 (10.0) 42.6 (9.1) 29.
ZDRS 37.0 (6.8) 38.7 (6.2) 30.
Hospital anxiety 6.2 (3.9) 7.0 (3.8) 3.7
Hospital depression 5.1 (3.6) 6.0 (3.6) 2.4
CAI 6.4 (3.1) 7.1 (3.1) 4.1
5.5 (2.5) 3.4
Abbreviations: ZDRS Zung-depression-rating-scale.in the PMN cells and scores in the trait anxiety, ZDRS,
and hospital depression scales, (Odds ratios 1.3, 1.3, and
1.5; P = 0.018, 0.023, and 0.038; Wald test, 5.6, 5.2, and
4.3 respectively). The same relations were found after
controlling for corticosteroids administration (Odds ratio
1.3, 1.4, 1.5; P, 0.021, 0.019, and 0.034; Wald test, 5.3, 5.5,
and 4.5, respectively). Moreover, a weaker but significant
correlation was established between the inducible HSP70
in PMN cells and the CAI (Odds ratio 1.654; P = 0.049;
Wald test 3.858) and similarly after controlling for cortico-
steroids administration (Odds ratio 1.649; P = 0.051; Wald
test = 1.649) (Table 3). Duration of the disease did not
correlate with the psychometric scores (Table 4) and
did not correlate with the HSP70 induction in the
PMN cells either (results not shown). Also, disease
activity did not correlate with HSP70 induction in
PMN cells. In the crosstabulation of disease activity
and HSP70 induction in PMN cells (Table 5), we ob-
served that the percentage of present/absent proteins
increases/decreases according to disease activity. The
statistical significance was examined by the chi-square
test and the results (Chi-square = 2,77; df = 2; Asymp.
Sig (two-sided) p = 0,2503) showed that there was no
statistical significance between HSP70 induction in MN
cells and disease activity.
Discussion
This study investigated the relationship between HSP70
induction in the surface epithelium, crypts, MC, and PMN
cells of colonic mucosa with levels of anxiety and de-
pression in patients with UC. It is the first published
study to show a positive psychological correlation be-
tween the induction of the cytoprotective, antiapoptotic
HSP70 in PMN cells that are known to perpetuate in-
flammation in UC patients.
As is already known, UC patients seem to have increased
sympathetic autonomic activity compared to controls, and
the severity of their symptoms is associated with measures
of personality-related anxiety, but not situational anxiety
[10]. It is of interest to note that our statistical evaluation
showed that anxiety as a personality trait had a strongerlation, and immunoreactivity of inducible HSP70
P70i PMN negative







1 (4.3) 0.001 0.028 0.034
9 (5.4) 0.002 0.001 0.001
0 (4.5) 0.007 0.006 0.002
(3.4) 0.056 0.048 0.070
(1.6) 0.019 0.018 0.019
(2.0) 0.026 0.028 0.033
(1.8)
Table 4 Correlations between psychometric scales and between duration of disease (in years) and psychometric scales
Duration of disease STAI1 STAI2 ZUNGDEPRESSION HA HD
Spearman’s rho Duration of Disease Correlation Coefficient 1,000 -,031 -,084 -,127 ,020 -,059
Sig. (2-tailed) . ,884 ,691 ,544 ,926 ,780
N 25 25 25 25 25 25
STAI1 Correlation Coefficient -,031 1,000 ,652** ,503** ,508** ,447*
Sig. (2-tailed) ,884 . ,000 ,005 ,005 ,015
N 25 29 29 29 29 29
STAI2 Correlation Coefficient -,084 ,652** 1,000 ,678** ,618** ,607**
Sig. (2-tailed) ,691 ,000 . ,000 ,000 ,000
N 25 29 29 29 29 29
ZUNGDEPRESSION Correlation Coefficient -,127 ,503** ,678** 1,000 ,334 ,512**
Sig. (2-tailed) ,544 ,005 ,000 . ,076 ,005
N 25 29 29 29 29 29
HA Correlation Coefficient ,020 ,508** ,618** ,334 1,000 ,671**
Sig. (2-tailed) ,926 ,005 ,000 ,076 . ,000
N 25 29 29 29 29 29
HD Correlation Coefficient -,059 ,447* ,607** ,512** ,671** 1,000
Sig. (2-tailed) ,780 ,015 ,000 ,005 ,000 .
N 25 29 29 29 29 29
*Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).
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PMN cells (Figure 3).
Histopathology revealed that PMN cells showed clear
expression of HSP70i in the biopsies of UC patients. We
also found sparse and weak HSP70 induction in the sur-
face epithelium and crypts. Although we used the same
antibody, our findings did not confirm previous observa-
tions of clear mucosal and submucosal staining of epithe-
lial and endothelial cells (where some immunoreactivity
has already been described for PMN as well) [22]. Our re-
sults, however, support evidence of HSP70i downregula-
tion in the biopsies of UC patients rendering their mucosa
vulnerable to inflammation-induced injury [19]. This ob-
servation supports the tenet that HSP cytoprotection mayTable 5 Disease activity and HSP70i PMN crosstabulation
HSP70i PMN Total
Absent Present
DISEASE ACTIVITY MILD Count 3 3 6
% 50,0% 50,0% 100,0%
ΜΕDIUM Count 3 14 17
% 17,65% 82,35% 100,0%
SEVERE Count 1 5 6
% 16,7% 83,3% 100,0%
Total Count 7 22 29
% 24,1% 75,9% 100,0%eventually become exhausted in any chronic disease which
causes massive protein misfolding and aggregation [16].
Additionally, the even more rare expression of HSP70i
that we observed in the crypts of UC specimens compared
to the surface epithelium agrees with previous results [19].
HSP70i becomes downregulated in the epithelium and
crypts, confirming previous research and rendering the
intestine more vulnerable to inflammation. Moreover,Figure 3 The relationship between the degrees of anxiety as a
trait (STAI2) and the presence or absence of HSP70
immunoreactivity in PMN cells. The number of patients is
depicted on the vertical axis, whereas the severity of anxiety –as
expressed through the State Trait Anxiety Inventory II (as a trait) is
depicted on the horizontal axis.
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epithelium) of most patients with active disease. PMN
cells are implicated in the autoimmune mechanism of
mucosal destruction in UC through the release of ROS.
Through the induction of HSP70i, PMN cells become
more resistant to apoptosis and cell death. The induc-
tion of HSP70i in PMN cells correlates with anxiety and
depression scores (and not with the downregulated
HSP70i of the epithelium).
Current research on IBD treatment is focusing on the
inhibition of PMN transmigration across mucosal epithelia
and on novel therapies that promote PMN apoptosis
[36-39]. HSP70 induction, which protects PMN cells from
apoptosis and at the same time significantly correlates
with the degree of anxiety and depression of UC patients,
might be a bringing point for the role that psycho-
logical factors play in the natural history of the disease,
as expressed by UC patients and observed in relevant
studies [4,6].
It would be of great clinical interest to clarify whether
the alleviation of anxiety and depression symptoms
decreases HSPi in PMN cells of the colon mucosa.
The increase of attenuation of HSP70 induction and
its anti-apoptotic effect on PMN relating to anxiety
and depression could serve as a useful biological marker
for the in-depth study of auto-immune and psychological
interventions in UC.
The cross-sectional design of our study does not allow
us to infer causality direction. The small sample size is a
limitation that we tried to counterbalance by the statis-
tical methods chosen. The homogeneity of the samples,
however, strengthens the results, as there is evidence that
the use of mixed samples from patients with UC and CD
is a persistent methodological flaw in human studies on
the impact of psychological factors on the course of the
IBD. This is because of the differences in the nature of the
two diseases. Also, prospective studies with mixed samples
have been almost entirely negative [23,40]. Moreover,
we did not compare the patients with active disease
(where we would observe HSP70 induction) with the
patients with quiescent disease, which could provide us
with more data.
Conclusion
In conclusion, our preliminary results have shown that
further studies on the psychosomatic nature of IBD are
warranted and should focus on the use of HSP70 as a
biological marker.
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